Popular on EntSun
- Systemores Launches Fork: Web-Native Interactive Video Engine Debuts With Thriller 'The Hollow' - 830
- Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 546
- New Horror Film from BayView Entertainment Dares Viewers to 'Invite the Devil to Come and Play' - 435
- Higginswerx and Mirrorize Unveil 'Mirror 9: The Hollowing' - 375
- "For Love Of Will," Staged Reading at Flea Theatre, NYC, Oct 26 - 355
- Hyperlens Studios Announces Planned Merger with Arclight, Ant Hill Productions, and Lemazing - 353
- Tickets On Sale Now for Chilling Horror-Thriller, 'One Eye Open' - 325
- Laurent Gabay on the Importance of Fashion Sourcing: Where to Find the Best Products Worldwide - 319
- Bay Street Yard announces Oktoberfest celebration Oct. 17 - 310
- Disney Streamer Network Establishes Creator Code of Conduct - 305
Similar on EntSun
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
- Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
- Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
- PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
- KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
Former Goddard Enterprises Managing Director Anthony Ali Joins STS Capital Partners as Managing Director and Partner
EntSun News/11105572
BRIDGETOWN, Barbados - EntSun -- STS Capital Partners is pleased to announce that Anthony Ali is joining the firm as Managing Director and Partner, bringing extensive international leadership experience and a proven track record in building enterprise value, acquisitions, and divestitures. Having spent more than a decade leading Goddard Enterprises Ltd. (GEL), a conglomerate spanning 130 companies across 27 countries, Anthony brings firsthand experience to business owners considering a sale and the advisors who support them. At STS, he will leverage this expertise integrated with the firm's Selling to Strategics™ process to help owners maximize value and achieve an Extraordinary Exit™.
As Managing Director of GEL from 2013 to 2026, Anthony helped scale the business from $600 million to over $2 billion in revenue, overseeing seven divisions across the Caribbean and Latin America. He led the company's restructuring, divestiture of non-core assets, and strategic expansion, including 15 acquisitions and 7 divestitures representing a total investment value of $1.2 billion.
More on EntSun News
"Anthony brings a unique perspective to STS, its advisors and its clients, having spent his career on the other side of the table, building businesses and making the strategic decisions that drive growth. As a high-performance operator, he understands what matters to business owners and what strategic buyers are looking for. We're excited to welcome him to the team," said Rob Follows, Founder and Chairman of STS Capital Partners.
Throughout his career, Anthony has held senior executive positions across technology, manufacturing, consumer goods, logistics, and distribution, with involvement in transactions totaling more than $2.1 billion. His experience includes leadership roles at Azerty Inc., where the business grew from $350 million to $1.2 billion during his tenure before its sale to United Stationers, as well as Thermo Fisher Scientific and Enerworks Inc. Earlier in his career, he was selected for a fellowship at McKinsey & Company. He also holds two patents, with two more pending, and has served on several international boards.
More on EntSun News
"Throughout my career, I've seen how the right strategic opportunities can transform a business and create significant value. What attracted me to STS is its commitment to looking beyond conventional valuations and identifying buyers who recognize a business's full strategic potential. I'm excited to bring my experience to the team and help owners achieve outcomes they may not have thought possible," said Anthony Ali, Managing Director and Partner at STS Capital Partners.
To connect with Anthony about exploring strategic exit opportunities and creating an Extraordinary Exit™ or becoming a referral advisor with specific industry expertise, feel free contact him at aali@stscapital.com or Rob Follows at rob@stscapital.com or visit stscapital.com.
As Managing Director of GEL from 2013 to 2026, Anthony helped scale the business from $600 million to over $2 billion in revenue, overseeing seven divisions across the Caribbean and Latin America. He led the company's restructuring, divestiture of non-core assets, and strategic expansion, including 15 acquisitions and 7 divestitures representing a total investment value of $1.2 billion.
More on EntSun News
- Who Won Milan Fashion Week SS27? Prada Led the Critics and the Media; Moschino Had the Top Debut
- EvilJay, comedian, Controversy King, Chicago, comedy, music
- HIRO Ostomy Belt Launch by Richard O'Hamill
- For the Husband Who Carries the Family: Husbands Deserve a Keepsake, Not Just a Tie
- Acclaimed Short Film Flowerz, Written And Directed By Crystal Manning, Earns Prestigious Nomination
"Anthony brings a unique perspective to STS, its advisors and its clients, having spent his career on the other side of the table, building businesses and making the strategic decisions that drive growth. As a high-performance operator, he understands what matters to business owners and what strategic buyers are looking for. We're excited to welcome him to the team," said Rob Follows, Founder and Chairman of STS Capital Partners.
Throughout his career, Anthony has held senior executive positions across technology, manufacturing, consumer goods, logistics, and distribution, with involvement in transactions totaling more than $2.1 billion. His experience includes leadership roles at Azerty Inc., where the business grew from $350 million to $1.2 billion during his tenure before its sale to United Stationers, as well as Thermo Fisher Scientific and Enerworks Inc. Earlier in his career, he was selected for a fellowship at McKinsey & Company. He also holds two patents, with two more pending, and has served on several international boards.
More on EntSun News
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
- Beyond a Single Project: Studio Valdivieso Makes the Case for Creative Partnership
- Black 11 Entertainment Launches Executive Networking Experiences for Las Vegas Conferences
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
"Throughout my career, I've seen how the right strategic opportunities can transform a business and create significant value. What attracted me to STS is its commitment to looking beyond conventional valuations and identifying buyers who recognize a business's full strategic potential. I'm excited to bring my experience to the team and help owners achieve outcomes they may not have thought possible," said Anthony Ali, Managing Director and Partner at STS Capital Partners.
To connect with Anthony about exploring strategic exit opportunities and creating an Extraordinary Exit™ or becoming a referral advisor with specific industry expertise, feel free contact him at aali@stscapital.com or Rob Follows at rob@stscapital.com or visit stscapital.com.
Source: STS Capital Partners
0 Comments
Latest on EntSun News
- Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
- Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
- The Green Room 42 Presents Vickie & Nickie's Holiday Sleigh Ride!
- PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
- KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
- The Truth, The Journey Within Makes Its Worldwide Premiere in Beverly Hills
- Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
- Prince's Collaborator Shelby J To Be A Special Guest For "a Deadly Proposal" Red Carpet
- Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
- NJT Closes 2026 Season with the Holiday Romantic Musical "She Loves Me"
- Claressa Shields Brings Out HipHop Heavyweights for Star Studded Atlanta Listening Party
- The Movie Guys Co-Founder Rodrigo Martinez Brings Big-Screen Production Quality to Mini Dramas
- Hitsquad Outdoors with Tim Sylvia joins forces with Hitmen and Country Raised to expand reach
- Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
- Pixel Swarm Drones Returns to IAAPA Expo in Orlando for Fourth Consecutive Year
- Craig Conover's Patch Work Debuts as an Instant New York Times and USA Today Bestseller
- World's Greatest! Segments Earn Three Honors at the 47th Annual Telly Awards
- IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
- FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
